0001437749-18-005723.txt : 20180328 0001437749-18-005723.hdr.sgml : 20180328 20180328170017 ACCESSION NUMBER: 0001437749-18-005723 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180327 FILED AS OF DATE: 20180328 DATE AS OF CHANGE: 20180328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roshan Hanif A CENTRAL INDEX KEY: 0001664441 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20190 FILM NUMBER: 18719552 MAIL ADDRESS: STREET 1: C/O AEON CLINICAL LABORATORIEXS STREET 2: 2225 CENTENNIAL DRIVE CITY: GAINESVILLE STATE: FL ZIP: 30504 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeon Global Health Corp. CENTRAL INDEX KEY: 0000885074 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 141673067 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 2225 CENTENNIAL DRIVE CITY: GAINESVILLE STATE: 2Q ZIP: 30504 BUSINESS PHONE: 888-661-0225 MAIL ADDRESS: STREET 1: 2225 CENTENNIAL DRIVE CITY: GAINESVILLE STATE: 2Q ZIP: 30504 FORMER COMPANY: FORMER CONFORMED NAME: AUTHENTIDATE HOLDING CORP DATE OF NAME CHANGE: 20010327 FORMER COMPANY: FORMER CONFORMED NAME: BITWISE DESIGNS INC DATE OF NAME CHANGE: 19930328 4 1 rdgdoc.xml FORM 4 X0306 4 2018-03-27 0000885074 Aeon Global Health Corp. AGHC 0001664441 Roshan Hanif A AEON GLOBAL HEALTH CORP. 2225 CENTENNIAL DR. GAINESVILLE GA 30504 1 1 1 Chairman and CEO Convertible Note 1.20 2018-03-27 4 A 0 504452 0 A 2018-03-27 2019-03-20 Common Stock 420376 504452 D Convertible Note 2.03 2018-03-27 4 D 0 255417 0 D 2017-03-20 2018-03-20 Common Stock 125821 0 D Convertible Note 1.20 2018-03-27 4 A 0 255417 0 A 2018-03-27 2019-03-20 Common Stock 212847 255417 D Effective on March 27, 2018 the registrant entered into a transaction with the reporting person to exchange a preexisting note originally issued to the reporting person on January 23, 2018 in the aggregate principal amount of $500,000 for a new note in the aggregate principal amount of $504,452 that is convertible into shares of the registrant's common stock. The new note is convertible at the initial conversion rate of $1.20 per share. Represents the number of shares of common stock issuable upon conversion of the principal amount of the convertible note at the initial conversion price of the convertible note. The reported transactions involve an amendment of a convertible note originally issued on March 20, 2017 to extend the maturity date and adjust the conversion price, resulting in the deemed cancellation of the old convertible note and the simultaneous issuance of a new convertible note, for purposes of Section 16. The reduction in the conversion price was in consideration of the Reporting Person extending the maturity date of the convertible note. /s/ Hanif A. Roshan 2018-03-28